LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $412,784 | +26.9% | 378,701 | +166.7% | 0.00% | – |
Q2 2023 | $325,194 | -11.7% | 142,006 | -6.3% | 0.00% | – |
Q1 2023 | $368,128 | +23.6% | 151,493 | -2.8% | 0.00% | – |
Q4 2022 | $297,780 | -20.4% | 155,906 | +0.2% | 0.00% | – |
Q3 2022 | $374,000 | -7.4% | 155,643 | -28.3% | 0.00% | – |
Q2 2022 | $404,000 | -11.0% | 217,197 | 0.0% | 0.00% | – |
Q1 2022 | $454,000 | -46.5% | 217,197 | +0.8% | 0.00% | – |
Q4 2021 | $849,000 | -71.1% | 215,541 | -11.8% | 0.00% | -100.0% |
Q2 2018 | $2,934,000 | +3.9% | 244,516 | -25.8% | 0.00% | 0.0% |
Q1 2018 | $2,823,000 | -13.3% | 329,429 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $3,255,000 | +125.9% | 329,429 | +181.0% | 0.00% | – |
Q3 2017 | $1,441,000 | -64.1% | 117,255 | -58.1% | 0.00% | -100.0% |
Q1 2017 | $4,013,000 | +15.2% | 279,874 | +11.1% | 0.00% | 0.0% |
Q4 2016 | $3,484,000 | -23.4% | 251,910 | +0.0% | 0.00% | 0.0% |
Q3 2016 | $4,550,000 | +32.6% | 251,806 | +5.3% | 0.00% | 0.0% |
Q2 2016 | $3,432,000 | – | 239,177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |